{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:39Z","timestamp":1793146719593,"version":"4.5.0"},"reference-count":47,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"MEYS, LRI CZECRIN","award":["LM2023049"],"award-info":[{"award-number":["LM2023049"]}]},{"name":"Ministry of Health, Czech Republic","award":["FNBr, 65269705"],"award-info":[{"award-number":["FNBr, 65269705"]}]},{"name":"MEYS Czech Republic","award":["MUNI\/A\/1568\/2024"],"award-info":[{"award-number":["MUNI\/A\/1568\/2024"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,22]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The goal of this study is to assess the safety, feasibility and clinical outcomes of prophylactic fibrinogen administration in paediatric scoliosis surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective, two-arm, randomised, double-blind pilot trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single-centre study conducted at a tertiary care hospital specialising in scoliosis surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>32 children undergoing scoliosis surgery entered and completed the study. The inclusion criteria were elective scoliosis surgery, age &lt;18 years, provision of a signed informed consent form by both parents and consent to contraception use for the duration of this clinical trial among sexually active (\u226515 years of age) participants. The exclusion criteria were diagnosed congenital or acquired coagulopathy, use of anticoagulants other than perioperative prophylactic administration of low molecular weight heparin to prevent venous thromboembolism, known hypersensitivity to the active substance or any excipients in the investigated medicinal product, history of deep vein thrombosis or pulmonary embolism, pregnancy and lactation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were randomised 1:1 to a standard group, receiving standard blood and coagulation management, or a fibrinogen group, receiving a single prophylactic dose of fibrinogen concentrate in addition to standard care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Safety, the primary objective, was assessed according to adverse events, serious adverse events and other safety parameters. Secondary objectives included feasibility and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the fibrinogen group, 101 adverse events across 19 types were observed, whereas in the standard group, 95 adverse events across 21 types (p&gt;0.9999) and one serious adverse event were observed. No adverse events of special interest or deaths occurred in either group. Blood loss did not significantly differ between the fibrinogen (1021.88\u2009mL (SD 473.63)) and standard (859.38\u2009mL (SD 713.03)) groups (p=0.1677). The mean length of hospital stay was 8.88 (SD 0.81) days in the fibrinogen group and 9.25 (SD 1.88) days in the standard group (p=0.9210). No statistically significant differences in the use of blood transfusions, blood derivatives, crystalloids or colloids were observed between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that the prophylactic administration of fibrinogen during scoliosis surgery in children is feasible and appears to be safe. Due to the limited sample size, no conclusions can be drawn regarding the efficacy of pre-emptive fibrinogen administration on clinical outcomes. However, the results provide valuable data to inform sample size calculation for a future full-scale randomised controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      CliniacalTrials.gov\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05391412\">NCT05391412<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-100137","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:25:17Z","timestamp":1759901117000},"page":"e100137","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of prophylactic fibrinogen concentrate in scoliosis surgery (EFISS): a randomised pilot trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05391412","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05391412","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jan","family":"Hudec","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Anaesthesiology and Intensive Care Medicine, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Vrbica","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Anaesthesiology and Intensive Care Medicine, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-5470","authenticated-orcid":false,"given":"Ondrej","family":"Hrdy","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Anaesthesiology and Intensive Care Medicine, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Galko","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Spine Surgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Orthopaedics and Spine Surgery, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Repko","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Spine Surgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Orthopaedics and Spine Surgery, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Stepanova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\/CZECRIN, Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Demlova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\/CZECRIN, Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5928-0383","authenticated-orcid":false,"given":"Michaela","family":"Kubelova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\/CZECRIN, Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gal","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Anaesthesiology and Intensive Care Medicine, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2025120415061094000_15.10.e100137.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-017-5346-6"},{"key":"2025120415061094000_15.10.e100137.2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.spinee.2020.01.008","article-title":"Prevalence of adolescent idiopathic scoliosis in Turkey: an epidemiological study","volume":"20","author":"Y\u0131lmaz","year":"2020","journal-title":"Spine J"},{"key":"2025120415061094000_15.10.e100137.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.08.007"},{"key":"2025120415061094000_15.10.e100137.4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MOP.0b013e328320a929","article-title":"Update on the management of idiopathic scoliosis","volume":"21","author":"Kim","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"2025120415061094000_15.10.e100137.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11832-012-0457-4"},{"key":"2025120415061094000_15.10.e100137.6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pcl.2020.09.012","article-title":"Pulmonary Implications of Pediatric Spinal Deformities","volume":"68","author":"Sheehan","year":"2021","journal-title":"Pediatr Clin North Am"},{"key":"2025120415061094000_15.10.e100137.7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.31128\/AJGP-06-20-5477","article-title":"Paediatric scoliosis: Update on assessment and treatment","volume":"49","author":"Parr","year":"2020","journal-title":"Aust J Gen Pract"},{"key":"2025120415061094000_15.10.e100137.8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.31616\/asj.2020.0263","article-title":"Neuromuscular Scoliosis: Comorbidities and Complications","volume":"15","author":"Weissmann","year":"2021","journal-title":"Asian Spine J"},{"key":"2025120415061094000_15.10.e100137.9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0310057X0403200413","article-title":"Anaesthesia for correction of scoliosis in children","volume":"32","author":"Gibson","year":"2004","journal-title":"Anaesth Intensive Care"},{"key":"2025120415061094000_15.10.e100137.10","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/anae.15124","article-title":"A randomised controlled trial of fibrinogen concentrate during scoliosis surgery","volume":"75","author":"Chen","year":"2020","journal-title":"Anaesthesia"},{"key":"2025120415061094000_15.10.e100137.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2010.03470.x"},{"key":"2025120415061094000_15.10.e100137.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137886","article-title":"Efficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-Analysis","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"2025120415061094000_15.10.e100137.13","article-title":"Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children","volume":"9","author":"McNicol","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120415061094000_15.10.e100137.14","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14331"},{"key":"2025120415061094000_15.10.e100137.15","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","article-title":"Fibrinogen and Fibrin in Hemostasis and Thrombosis","volume":"37","author":"Kattula","year":"2017","journal-title":"ATVB"},{"key":"2025120415061094000_15.10.e100137.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071547","article-title":"Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery (EFISS): a study protocol of two-arm, randomised trial","volume":"13","author":"Vrbica","year":"2023","journal-title":"BMJ Open"},{"key":"2025120415061094000_15.10.e100137.17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.hoc.2021.07.011","article-title":"Disorders of Fibrinogen and Fibrinolysis","volume":"35","author":"May","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025120415061094000_15.10.e100137.18","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.SPINE14620"},{"key":"2025120415061094000_15.10.e100137.19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jspd.2017.05.001","article-title":"Is Preoperative Fibrinogen Testing Associated With Total Blood Loss in Adolescent Idiopathic Scoliosis Correction?","volume":"5","author":"Geck","year":"2017","journal-title":"Spine Deform"},{"key":"2025120415061094000_15.10.e100137.20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jspd.2018.12.001","article-title":"Relationship Between Preoperative Plasma Fibrinogen Concentration, Perioperative Bleeding, and Transfusions in Elective Adult Spinal Deformity Correction","volume":"7","author":"Geck","year":"2019","journal-title":"Spine Deform"},{"key":"2025120415061094000_15.10.e100137.21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.thromres.2016.01.001","article-title":"Preoperative plasma fibrinogen concentration, factor XIII activity, perioperative bleeding, and transfusions in elective orthopaedic surgery: A prospective observational study","volume":"139","author":"Carling","year":"2016","journal-title":"Thromb Res"},{"key":"2025120415061094000_15.10.e100137.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1709255114"},{"key":"2025120415061094000_15.10.e100137.23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002066","article-title":"Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery","volume":"4","author":"Ranucci","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025120415061094000_15.10.e100137.24","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13575"},{"key":"2025120415061094000_15.10.e100137.25","doi-asserted-by":"crossref","first-page":"110373","DOI":"10.1016\/j.jclinane.2021.110373","article-title":"Fibrinogen prophylaxis for reducing perioperative bleeding in patients undergoing radical cystectomy: A double-blind placebo-controlled randomized trial","volume":"73","author":"Fathi","year":"2021","journal-title":"J Clin Anesth"},{"key":"2025120415061094000_15.10.e100137.26","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aev136"},{"key":"2025120415061094000_15.10.e100137.27","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"2025120415061094000_15.10.e100137.28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016","volume":"34","author":"Kozek-Langenecker","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"2025120415061094000_15.10.e100137.29","unstructured":"European Parliament and Council of the European Union . Directive 2001\/20\/EC of the european parliament and the council of 4 Apr 2001. OJ L 121: 34\u201344. 2001. Available: https:\/\/eur-lex.europa.eu\/eli\/dir\/2001\/20\/oj [Accessed 29 Dec 2024]."},{"key":"2025120415061094000_15.10.e100137.30","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20247"},{"key":"2025120415061094000_15.10.e100137.31","doi-asserted-by":"crossref","unstructured":"Thabane L , Ma J , Chu R , et al . A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10. doi:10.1186\/1471-2288-10-1","DOI":"10.1186\/1471-2288-10-1"},{"key":"2025120415061094000_15.10.e100137.32","doi-asserted-by":"publisher","DOI":"10.1111\/j..2002.384.doc.x"},{"key":"2025120415061094000_15.10.e100137.33","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-020-00634-w","article-title":"Guidance for conducting feasibility and pilot studies for implementation trials","volume":"6","author":"Pearson","year":"2020","journal-title":"Pilot Feasibility Stud"},{"key":"2025120415061094000_15.10.e100137.34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00264-010-1128-z","article-title":"Occurrence of fever in the first postoperative week does not help to diagnose infection in clean orthopaedic surgery","volume":"35","author":"U\u00e7kay","year":"2011","journal-title":"International Orthopaedics (SICOT)"},{"key":"2025120415061094000_15.10.e100137.35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00590-020-02637-y","article-title":"Blood and fluid management during scoliosis surgery: a single-center retrospective analysis","volume":"30","author":"Koraki","year":"2020","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"2025120415061094000_15.10.e100137.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-017-5456-1"},{"key":"2025120415061094000_15.10.e100137.37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s43390-022-00508-6","article-title":"Complications following surgical treatment of adolescent idiopathic scoliosis: a 10-year prospective follow-up study","volume":"10","author":"Hariharan","year":"2022","journal-title":"Spine Deform"},{"key":"2025120415061094000_15.10.e100137.38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.spinee.2018.05.033","article-title":"Surgical treatment of early-onset idiopathic scoliosis in the United States: a trend analysis of 15 years (1997-2012)","volume":"19","author":"Rustagi","year":"2019","journal-title":"Spine J"},{"key":"2025120415061094000_15.10.e100137.39","doi-asserted-by":"publisher","DOI":"10.1097\/BPB.0000000000000543"},{"key":"2025120415061094000_15.10.e100137.40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jspd.2016.09.001","article-title":"National Trends in the Surgical Management of Adolescent Idiopathic Scoliosis: Analysis of a National Estimate of 60,108 Children From the National Inpatient Sample Over a 13-Year Time Period in the United States","volume":"5","author":"Theologis","year":"2017","journal-title":"Spine Deform"},{"key":"2025120415061094000_15.10.e100137.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2021.01.004"},{"key":"2025120415061094000_15.10.e100137.42","unstructured":"Regulation (EU) no 536\/2014 of the European parliament and of the council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing directive 2001\/20\/EC. OJ L 158, 1-76. 2014. Available: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32014R0536 [Accessed 29 Dec 2024]."},{"key":"2025120415061094000_15.10.e100137.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-021-04681-z","article-title":"Hidden blood loss in adolescent idiopathic scoliosis patients undergoing posterior spinal fusion surgery: a retrospective study of 765 cases at a single centre","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"2025120415061094000_15.10.e100137.44","doi-asserted-by":"crossref","DOI":"10.1186\/1748-7161-5-16","article-title":"Intraoperative blood loss during different stages of scoliosis surgery: A prospective study","volume":"5","author":"Modi","year":"2010","journal-title":"Scoliosis"},{"key":"2025120415061094000_15.10.e100137.45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00586-016-4803-y","article-title":"Single vs two attending senior surgeons: assessment of intra-operative blood loss at different surgical stages of posterior spinal fusion surgery in Lenke 1 and 2 adolescent idiopathic scoliosis","volume":"26","author":"Kwan","year":"2017","journal-title":"Eur Spine J"},{"key":"2025120415061094000_15.10.e100137.46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/aas.13540","article-title":"The prophylactic use of fibrinogen concentrate in high-risk cardiac surgery","volume":"64","author":"Kwapisz","year":"2020","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025120415061094000_15.10.e100137.47","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610366437"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-100137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:08:37Z","timestamp":1764889717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-100137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,7]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/bmjopen-2025-100137"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-100137","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}